Redmynd

Redmynd scans for neurological decline, such as Alzheimer's disease and dementia using images of the retina. Millions of neural network experiments have created a sensitive and accurate tool. In a split-second, the retina is examined by a chain of neural networks to look for signals associated with neurological risk. The experience is non-invasive and quick: patients and doctors together can monitor, prevent, and protect. Prevention translates into years of quality life, lightening the unbearable burden of Alzheimer's disease and mental decline.